NCT04295577 Multi-Centre Observational Study of Maintenance Niraparib in Treatment of Ovarian CanceR Status COMPLETED Phase N/A
NCT04294927 TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention Status RECRUITING Phase NA
NCT04284852 Niraparib Maintenance in Patients With Advanced Ovarian Cancer at Neoadjuvant Setting Status COMPLETED Phase PHASE2
NCT04284631 Prognostic Value of Her2neu and EGFR in Primary Ovarian High Grade Serous Carcinoma. Status COMPLETED Phase N/A
NCT04282356 Intensive Intraperitoneal Therapy in Advanced Ovarian Cancer Status RECRUITING Phase PHASE2
NCT04280185 HIPEC in the Treatment of Stage IIc-IV Epithelial Ovarian Cancer After CRS (HIPECOC) Status UNKNOWN Phase NA
NCT04267939 ATR Inhibitor Elimusertib (BAY1895344) Plus Niraparib Phase 1b Study in Advanced Solid Tumors and Ovarian Cancer Status TERMINATED Phase PHASE1
NCT04260802 A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers Status TERMINATED Phase PHASE1/PHASE2
NCT04244552 A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies Status TERMINATED Phase PHASE1
NCT04239014 A Study to Evaluate the Effectiveness and Tolerability of a Second Maintenance Treatment in Participants With Ovarian Cancer, Who Have Previously Received Polyadenosine 5'Diphosphoribose [Poly (ADP Ribose)] Polymerase Inhibitor (PARPi) Treatment. Status WITHDRAWN Phase PHASE2
NCT04237090 Feasibility of a Clinical Trial Comparing the Use of Cetirizine to Replace Diphenhydramine in the Prevention of Reactions Related to Paclitaxel Status COMPLETED Phase PHASE3
NCT04234243 HIPEC in Ovarian Cancer, Case-Controls Study With 10-years Follow up Status COMPLETED Phase N/A
NCT04234113 Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors Status TERMINATED Phase PHASE1
NCT04229615 A Study of Fluzoparib±Apatinib Versus Placebo Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on First-Line Platinum-Based Chemotherapy Status UNKNOWN Phase PHASE3
NCT04227522 Rucaparib MAintenance After Bevacizumab Maintenance Following Carboplatin Based First Line Chemotherapy in Ovarian Cancer Patients Status COMPLETED Phase PHASE3